These findings highlight ACSL1 and ACSL4 as promising therapeutic targets for diabetes, with their mechanisms closely related to lipid metabolism, lipid peroxidation, inflammation, and ferroptosis. This evidence concerns the gene ACSL4 and diabetes mellitus.